InterOcean Capital Group’s Pfizer PFE Stock Holding History

InterOcean Capital Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$719K	Buy	25,911 +47	+0.2%	+$1.3K	0.02%	257
2023 Q4	$745K	Buy	25,864 +1,291	+5%	+$39K	0.02%	234
2023 Q3	$815K	Sell	24,573 -8,801	-26%	-$311K	0.02%	210
2023 Q2	$1.22M	Sell	33,374 -280,836	-89%	-$10.9M	0.04%	158
2023 Q1	$12.8M	Sell	314,210 -54,463	-15%	-$2.35M	0.43%	59
2022 Q4	$18.9M	Sell	368,673 -28,820	-7%	-$1.38M	0.69%	42
2022 Q3	$17.4M	Sell	397,493 -37,591	-9%	-$1.83M	0.71%	44
2022 Q2	$22.8M	Sell	435,084 -10,795	-2%	-$550K	0.93%	36
2022 Q1	$23.1M	Sell	445,879 -26,601	-6%	-$1.38M	0.98%	34
2021 Q4	$27.9M	Buy	472,480 +17,670	+4%	+$875K	1.21%	29
2021 Q3	$19.6M	Buy	454,810 +233,623	+106%	+$10.3M	0.98%	34
2021 Q2	$8.66M	Buy	221,187 +52,685	+31%	+$2.05M	0.44%	49
2021 Q1	$6.11M	Buy	168,502 +108,432	+181%	+$3.85M	0.34%	55
2020 Q4	$2.21M	Buy	+60,070	New	+$2.2M	0.14%	72

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

InterOcean Capital Group's PFE Position: Q1 2024 in Review

InterOcean Capital Group increased its Pfizer (PFE) stake by 0.18% in Q1 2024, buying an estimated $1.3K and bringing the position to 25,911 shares worth $719K. The position accounts for 0.02% of the portfolio, ranked #257.

InterOcean Capital Group first reported a position in PFE in Q4 2020 and has held it in 14 quarters since. The position peaked at $27.9M in Q4 2021. 2,875 funds tracked by Wall St. Rank hold PFE as of Q1 2024.

InterOcean Capital Group held 25,911 shares of Pfizer worth $719K as of Q1 2024.
InterOcean Capital Group bought 47 Pfizer shares in Q1 2024, an estimated $1.3K.
Pfizer made up 0.02% of InterOcean Capital Group's portfolio in Q1 2024, its #257 holding.
InterOcean Capital Group first reported a position in Pfizer in Q4 2020 and has held it in 14 quarters since.
InterOcean Capital Group's Pfizer position peaked at $27.9M in Q4 2021.
2,875 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.

Based on InterOcean Capital Group's 13F filing for Q1 2024, filed 13 May 2024.